Cite
HARVARD Citation
Iannone, F. et al. (2016). Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability. Clinical rheumatology. 35 (11), pp. 2649-2656. [Online].